How Much Does Pronidesivir (GS-441524) Cost
Feline Infectious Peritonitis (FIP) remains one of the most challenging and fatal diseases affecting cats worldwide. Caused by a coronavirus, FIP can lead to severe symptoms such as loss of appetite, lethargy, fever, abdominal or thoracic fluid buildup, lymphadenopathy, granulomas, neurological damage, and uveitis. Historically, effective treatment options for FIP were limited, making it a daunting diagnosis for pet owners and veterinarians alike.
NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, has emerged as a groundbreaking antiviral therapy for FIP. Approved by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, NeoFipronis is the world’s first officially registered oral medication specifically targeting FIP in cats. Its approval marks a significant milestone in feline medicine, offering a safe, non-invasive, and highly effective treatment option. The drug boasts rapid absorption, a strong safety profile, minimal side effects, and excellent tolerability, making it a preferred choice in FIP management.
The core component, GS-441524, is a nucleoside analog that inhibits viral replication, showing remarkable success in clinical trials and real-world applications. Treatment protocols involve administering the medication based on the cat's weight—generally 15 mg per kg (half a tablet) once daily. For neurological or ocular forms of FIP, dosage may be increased to 30 mg/kg under veterinary supervision. It’s recommended to give the medication on an empty stomach, either an hour before meals or two hours after eating, to optimize absorption.
Continuous treatment is critical, with a recommended duration of no less than 12 weeks to ensure complete viral clearance. Adherence to the prescribed dosage without omission is vital to prevent relapse or resistance. During therapy, pet owners should monitor their cats closely for changes in appetite, activity levels, body temperature, and overall health. Regular veterinary checkups, including blood tests and liver and kidney function assessments, are essential throughout the treatment process.
Pricing for Pronidesivir (GS-441524) varies significantly depending on geographic location, source, and supplier. As a medication with high demand and limited official distribution channels, the cost can be substantial. Typical prices range from approximately $200 to $500 per 10 ml vial, with each vial containing enough for a few weeks of treatment when doses are calculated per kilogram. The total cost for a complete 12-week treatment course can range from $2,000 to over $6,000. These figures reflect the current market price, which is influenced by factors such as supply chain, import tariffs, and vendor markups.
Because of its status as a non-prescription drug, NeoFipronis is often available through online sources, veterinary pharmacies, or specialized pet medication suppliers. However, safety and product authenticity are paramount; only purchase from reputable sources or official websites to guarantee quality and avoid counterfeit products.
In summary, Pronidesivir (GS-441524) has transformed the treatment landscape for FIP in cats, offering hope for affected pets and their owners. While the cost can be considerable, the high efficacy, safety, and potential for curing a previously fatal disease make it a valuable investment in feline health. Always consult a qualified veterinarian before starting therapy, and ensure you acquire the medication through trusted channels to ensure safety and effectiveness.
